QDEL - Quidel Corporation -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Quidel Corporation
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.
IPO Date: February 1, 1991
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $844.16M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.99 | 2.20%
Avg Daily Range (30 D): $0.34 | 2.78%
Avg Daily Range (90 D): $0.59 | 4.05%
Institutional Daily Volume
Avg Daily Volume: .43M
Avg Daily Volume (30 D): 1.27M
Avg Daily Volume (90 D): 1.3M
Trade Size
Avg Trade Size (Sh.): 75
Avg Trade Size (Sh.) (30 D): 74
Avg Trade Size (Sh.) (90 D): 65
Institutional Trades
Total Institutional Trades: 9,023
Avg Institutional Trade: $2.45M
Avg Institutional Trade (30 D): $2.59M
Avg Institutional Trade (90 D): $2.9M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $5.12M
Avg Closing Trade (30 D): $2.79M
Avg Closing Trade (90 D): $3.41M
Avg Closing Volume: 89.23K
 
News
Aug 31, 2026 @ 9:04 AM
Lateral Flow Assay Market Size, Industry Dynamics,...
Source: Researchandmarkets.Com
May 8, 2026 @ 8:47 AM
Pregnancy Detection Kits Market Analysis Report 20...
Source: Researchandmarkets.Com
Mar 9, 2026 @ 1:05 PM
Rice Hall James Buys QuidelOrtho Stock
Source: John Ballard
Mar 2, 2026 @ 2:18 AM
QuidelOrtho Corp Director Purchases 10k Shares as ...
Source: Adé Hennis
Sep 4, 2025 @ 9:35 PM
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is ...
Source: Bragar Eagel & Squire, P.C.
Financials
  TTM Q2 2027 Q4 2026
Basic EPS $-15.39 $-1.36 $-1.35
Diluted EPS $-15.39 $-1.36 $-1.35
Revenue $2.67B $630.9M $619.8M
Gross Profit
Net Income / Loss $-1048.4M $-92.9M $-91.8M
Operating Income / Loss $-824.7M $-21.8M $-31.8M
Cost of Revenue
Net Cash Flow $-28.3M $-29.4M
PE Ratio